Details for 2019833416

Up to date per 22.05.2026

Actions

Title / Product Name

VERWENDUNG VON ASPARAGINASE ZUSAMMEN MIT HEMMUNG VON GSK3A ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019833416

EP Publication Number

3820461

E-Number

1875241

Language

PCT Number

US19041555

Publication Date

19.05.2021 A

07.01.2026 B1

Registration Date

07.01.2026

AT Publication Date

15.01.2026

Application Date

12.07.2019

Registration Number

Priorities

12.07.2018

201862697053 P

26.10.2018

201862751129 P

29.04.2019

201962839912 P

IPC

A61K 38/50 20060101AFI20220302BHEP

Maximum Duration of Protection

12.07.2039

Owner

The Children's Medical Center Corporation55 Shattuck Street Boston, MA 02115US

Representative

No representatives present

Inventor

GUTIERREZ, Alejandroc/o The Children's Medical Center Corporation 55 Shattuck Street Boston, MA 02115US

HINZE, Laurac/o The Children's Medical Center Corporation 55 Shattuck Street Boston, MA 02115US